{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T12:16:17Z","timestamp":1790252177355,"version":"4.1.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100001167","name":"Larry L. Hillblom Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001167","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Stanford ADRC"},{"name":"D.H. Chen Foundation"},{"name":"Knight Initiative for Brain Resilience"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurodegeneration"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Alzheimer\u2019s disease (AD) is a progressive neurodegenerative disorder characterized by cognitive decline and pathological hallmarks, including amyloid plaques, tau tangles, microgliosis, and chronic neuroinflammation. Over the past decade, advances in human genetics have revealed microglia and the innate immune pathways are central determinants of AD susceptibility, resilience, and progression, fundamentally redefining the recent conceptual framework of AD research. Genome-wide association studies (GWAS) implicate microglia-enriched genes including triggering receptor expressed on myeloid cells 2 (TREM2), phospholipase-C gamma 2 (PLCG2), and inositol polyphosphate-5-phosphatase D (INPP5D). Among these, the rare PLCG2 P522R variant is associated with reduced AD risk, enhanced microglial responsiveness, and enrichment in cognitively healthy centenarians. Single-cell and spatial transcriptomic studies have uncovered substantial microglial heterogeneity and pronounced region-specific alterations across age and disease progression. These analyses show that microglia transition through a spectrum of transcriptionally distinct states regulated by coordinated remodeling of lipid metabolic, phagocytic and lysosomal pathways, as well as cytokine-receptor signaling networks. Depending on the direction of these state transitions, microglia may engage neuroprotective programs that enhance debris clearance, maintain tissue homeostasis, and support repair, or alternatively, enter maladaptive states characterized by defective lipid processing, chronic inflammatory signaling, and heightened neurotoxicity. Here, we review genetic, molecular, and pharmacological evidence supporting PLCG2 as a compelling therapeutic target in AD. We integrate insights from transcriptomic and structural analyses, iPSC-derived microglia, and in vivo models that show how PLCG2 modulates microglial states, promotes brain resilience, and mitigates AD-related pathophysiology. We also highlight recent progress in identifying small-molecule PLCG2 activators via high-throughput lipid-vesicle assays and affinity-selection mass spectrometry. Collectively, these multidisciplinary advances position PLCG2 as a genetically validated, mechanistically tractable, and pharmacologically actionable target for precision immune-modulation strategies aimed at preserving cognition and enhancing resilience in brain aging and AD.<\/jats:p>","DOI":"10.1186\/s13024-026-00935-3","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T15:03:38Z","timestamp":1774537418000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["PLCG2 signaling and genetic resilience in Alzheimer\u2019s disease"],"prefix":"10.1186","volume":"21","author":[{"given":"Andy P.","family":"Tsai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amara K.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Mi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ava E.","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Ramirez Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony","family":"Wyss-Coray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,26]]},"reference":[{"key":"935_CR1","doi-asserted-by":"publisher","unstructured":"DeTure MA, Dickson DW. The neuropathological diagnosis of Alzheimer\u2019s disease. Mol Neurodegeneration. 2019;14. https:\/\/doi.org\/10.1186\/s13024-019-0333-5.","DOI":"10.1186\/s13024-019-0333-5"},{"key":"935_CR2","doi-asserted-by":"publisher","unstructured":"Kloske CM, Mahinrad S, Barnum CJ, Batista AF, Bradshaw EM, Butts B, Carrillo MC, Chakrabarty P, Chen X, Craft S, et al. Advancements in Immunity and Dementia Research: Highlights from the 2023 AAIC Advancements: Immunity Conference. Alzheimers Dement. 2025;21(e14291). https:\/\/doi.org\/10.1002\/alz.14291.","DOI":"10.1002\/alz.14291"},{"key":"935_CR3","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.jconrel.2024.01.047","volume":"367","author":"B Singh","year":"2024","unstructured":"Singh B, Day CM, Abdella S, Garg S. Alzheimer\u2019s disease current therapies, novel drug delivery systems and future directions for better disease management. J Control Release. 2024;367:402\u201324. https:\/\/doi.org\/10.1016\/j.jconrel.2024.01.047.","journal-title":"J Control Release"},{"key":"935_CR4","doi-asserted-by":"publisher","unstructured":"2024 Alzheimer\u2019s disease facts and figures. Alzheimers Dement. 2024;20:3708\u20133821. https:\/\/doi.org\/10.1002\/alz.13809.","DOI":"10.1002\/alz.13809"},{"key":"935_CR5","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13024-024-00719-7","volume":"19","author":"LE de Vries","year":"2024","unstructured":"de Vries LE, Huitinga I, Kessels HW, Swaab DF, Verhaagen J. The concept of resilience to Alzheimer\u2019s Disease: current definitions and cellular and molecular mechanisms. Mol Neurodegener. 2024;19:33. https:\/\/doi.org\/10.1186\/s13024-024-00719-7.","journal-title":"Mol Neurodegener"},{"key":"935_CR6","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1126\/science.abb8575","volume":"370","author":"A Sierksma","year":"2020","unstructured":"Sierksma A, Escott-Price V, De Strooper B. Translating genetic risk of Alzheimer\u2019s disease into mechanistic insight and drug targets. Science. 2020;370:61\u20136. https:\/\/doi.org\/10.1126\/science.abb8575.","journal-title":"Science"},{"key":"935_CR7","doi-asserted-by":"publisher","first-page":"105303","DOI":"10.1016\/j.nbd.2021.105303","volume":"153","author":"AP Tsai","year":"2021","unstructured":"Tsai AP, Lin PB, Dong C, Moutinho M, Casali BT, Liu Y, Lamb BT, Landreth GE, Oblak AL, Nho K. INPP5D expression is associated with risk for Alzheimer\u2019s disease and induced by plaque-associated microglia. Neurobiol Dis. 2021;153:105303. https:\/\/doi.org\/10.1016\/j.nbd.2021.105303.","journal-title":"Neurobiol Dis"},{"key":"935_CR8","doi-asserted-by":"publisher","first-page":"3417","DOI":"10.1038\/s41467-021-22491-8","volume":"12","author":"I de Rojas","year":"2021","unstructured":"de Rojas I, Moreno-Grau S, Tesi N, Grenier-Boley B, Andrade V, Jansen IE, Pedersen NL, Stringa N, Zettergren A, Hern\u00e1ndez I, et al. Common variants in Alzheimer\u2019s disease and risk stratification by polygenic risk scores. Nat Commun. 2021;12:3417. https:\/\/doi.org\/10.1038\/s41467-021-22491-8.","journal-title":"Nat Commun"},{"key":"935_CR9","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1038\/ng.3916","volume":"49","author":"R Sims","year":"2017","unstructured":"Sims R, van der Lee SJ, Naj AC, Bellenguez C, Badarinarayan N, Jakobsdottir J, Kunkle BW, Boland A, Raybould R, Bis JC, et al. Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer\u2019s disease. Nat Genet. 2017;49:1373\u201384. https:\/\/doi.org\/10.1038\/ng.3916.","journal-title":"Nat Genet"},{"key":"935_CR10","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s41588-019-0358-2","volume":"51","author":"BW Kunkle","year":"2019","unstructured":"Kunkle BW, Grenier-Boley B, Sims R, Bis JC, Damotte V, Naj AC, Boland A, Vronskaya M, van der Lee SJ, Amlie-Wolf A, et al. Genetic meta-analysis of diagnosed Alzheimer\u2019s disease identifies new risk loci and implicates A\u03b2, tau, immunity and lipid processing. Nat Genet. 2019;51:414\u201330. https:\/\/doi.org\/10.1038\/s41588-019-0358-2.","journal-title":"Nat Genet"},{"key":"935_CR11","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/s41588-022-01024-z","volume":"54","author":"C Bellenguez","year":"2022","unstructured":"Bellenguez C, K\u00fc\u00e7\u00fckali F, Jansen IE, Kleineidam L, Moreno-Grau S, Amin N, Naj AC, Campos-Martin R, Grenier-Boley B, Andrade V, et al. New insights into the genetic etiology of Alzheimer\u2019s disease and related dementias. Nat Genet. 2022;54:412\u201336. https:\/\/doi.org\/10.1038\/s41588-022-01024-z.","journal-title":"Nat Genet"},{"key":"935_CR12","doi-asserted-by":"publisher","unstructured":"Phongpreecha T, Fernandez R, Mrdjen D, Culos A, Gajera CR, Wawro AM, Stanley N, Gaudilliere B, Poston KL, Aghaeepour N, Montine TJ. Single-cell peripheral immunoprofiling of Alzheimer\u2019s and Parkinson\u2019s diseases. Sci Adv. 2020;6. https:\/\/doi.org\/10.1126\/sciadv.abd5575.","DOI":"10.1126\/sciadv.abd5575"},{"key":"935_CR13","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13195-019-0469-0","volume":"11","author":"L Magno","year":"2019","unstructured":"Magno L, Lessard CB, Martins M, Lang V, Cruz P, Asi Y, Katan M, Bilsland J, Lashley T, Chakrabarty P, et al. Alzheimer\u2019s disease phospholipase C-gamma-2 (PLCG2) protective variant is a functional hypermorph. Alzheimers Res Ther. 2019;11:16. https:\/\/doi.org\/10.1186\/s13195-019-0469-0.","journal-title":"Alzheimers Res Ther"},{"key":"935_CR14","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13073-022-01022-0","volume":"14","author":"AP Tsai","year":"2022","unstructured":"Tsai AP, Dong C, Lin PB, Messenger EJ, Casali BT, Moutinho M, Liu Y, Oblak AL, Lamb BT, Landreth GE, et al. PLCG2 is associated with the inflammatory response and is induced by amyloid plaques in Alzheimer\u2019s disease. Genome Med. 2022;14:17. https:\/\/doi.org\/10.1186\/s13073-022-01022-0.","journal-title":"Genome Med"},{"key":"935_CR15","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1016\/j.immuni.2023.08.008","volume":"56","author":"AP Tsai","year":"2023","unstructured":"Tsai AP, Dong C, Lin PB, Oblak AL, Di Viana G, Wang N, Hajicek N, Carr AJ, Lendy EK, Hahn O, et al. Genetic variants of phospholipase C-\u03b32 alter the phenotype and function of microglia and confer differential risk for Alzheimer\u2019s disease. Immunity. 2023;56:2121\u2013e21362126. https:\/\/doi.org\/10.1016\/j.immuni.2023.08.008.","journal-title":"Immunity"},{"key":"935_CR16","doi-asserted-by":"publisher","unstructured":"Tsai AP, Henze DE, Ramirez Lopez E, Haberberger J, Dong C, Lu N, Atkins M, Costa EK, Farinas A, Oh HS-H, et al. Spatial and molecular insights into microglial roles in cerebellar aging. bioRxiv. 2025;202520032001640978. https:\/\/doi.org\/10.1101\/2025.03.01.640978.","DOI":"10.1101\/2025.03.01.640978"},{"key":"935_CR17","doi-asserted-by":"publisher","first-page":"3513","DOI":"10.1016\/j.neuron.2022.10.015","volume":"110","author":"C Romero-Molina","year":"2022","unstructured":"Romero-Molina C, Garretti F, Andrews SJ, Marcora E, Goate AM. Microglial efferocytosis: Diving into the Alzheimer\u2019s disease gene pool. Neuron. 2022;110:3513\u201333. https:\/\/doi.org\/10.1016\/j.neuron.2022.10.015.","journal-title":"Neuron"},{"key":"935_CR18","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1083\/jcb.201709069","volume":"217","author":"DV Hansen","year":"2018","unstructured":"Hansen DV, Hanson JE, Sheng M. Microglia in Alzheimer\u2019s disease. J Cell Biol. 2018;217:459\u201372. https:\/\/doi.org\/10.1083\/jcb.201709069.","journal-title":"J Cell Biol"},{"key":"935_CR19","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/s41593-019-0566-1","volume":"23","author":"J Marschallinger","year":"2020","unstructured":"Marschallinger J, Iram T, Zardeneta M, Lee SE, Lehallier B, Haney MS, Pluvinage JV, Mathur V, Hahn O, Morgens DW, et al. Lipid-droplet-accumulating microglia represent a dysfunctional and proinflammatory state in the aging brain. Nat Neurosci. 2020;23:194\u2013208. https:\/\/doi.org\/10.1038\/s41593-019-0566-1.","journal-title":"Nat Neurosci"},{"key":"935_CR20","doi-asserted-by":"publisher","first-page":"116624","DOI":"10.1016\/j.celrep.2025.116624","volume":"44","author":"AP Tsai","year":"2025","unstructured":"Tsai AP, Henze DE, Ramirez Lopez E, Haberberger J, Dong C, Lu N, Atkins M, Costa EK, Farinas A, Oh HS, et al. Spatial and single-cell transcriptomics reveal the reorganization of cerebellar microglia with aging. Cell Rep. 2025;44:116624. https:\/\/doi.org\/10.1016\/j.celrep.2025.116624.","journal-title":"Cell Rep"},{"key":"935_CR21","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1056\/NEJMoa1211103","volume":"368","author":"T Jonsson","year":"2013","unstructured":"Jonsson T, Stefansson H, Steinberg S, Jonsdottir I, Jonsson PV, Snaedal J, Bjornsson S, Huttenlocher J, Levey AI, Lah JJ, et al. Variant of TREM2 associated with the risk of Alzheimer\u2019s disease. N Engl J Med. 2013;368:107\u201316. https:\/\/doi.org\/10.1056\/NEJMoa1211103.","journal-title":"N Engl J Med"},{"key":"935_CR22","doi-asserted-by":"publisher","unstructured":"Moutinho M, Coronel I, Tsai AP, Di Prisco GV, Pennington T, Atwood BK, Puntambekar SS, Smith DC, Martinez P, Han S, et al. TREM2 splice isoforms generate soluble TREM2 species that disrupt long-term potentiation. Genome Med 2023;15:11. https:\/\/doi.org\/10.1186\/s13073-023-01160-z","DOI":"10.1186\/s13073-023-01160-z"},{"key":"935_CR23","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.it.2024.08.001","volume":"45","author":"Y Chen","year":"2024","unstructured":"Chen Y, Holtzman DM. New insights into innate immunity in Alzheimer\u2019s disease: from APOE protective variants to therapies. Trends Immunol. 2024;45:768\u201382. https:\/\/doi.org\/10.1016\/j.it.2024.08.001.","journal-title":"Trends Immunol"},{"key":"935_CR24","doi-asserted-by":"publisher","unstructured":"Shinohara M, Kanekiyo T, Tachibana M, Kurti A, Shinohara M, Fu Y, Zhao J, Han X, Sullivan PM, Rebeck GW, et al. APOE2 is associated with longevity independent of Alzheimer\u2019s disease. Elife 2020;9. https:\/\/doi.org\/10.7554\/eLife.62199.","DOI":"10.7554\/eLife.62199"},{"key":"935_CR25","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13024-022-00574-4","volume":"17","author":"AC Raulin","year":"2022","unstructured":"Raulin AC, Doss SV, Trottier ZA, Ikezu TC, Bu G, Liu CC. ApoE in Alzheimer\u2019s disease: pathophysiology and therapeutic strategies. Mol Neurodegener. 2022;17:72. https:\/\/doi.org\/10.1186\/s13024-022-00574-4.","journal-title":"Mol Neurodegener"},{"key":"935_CR26","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13024-020-00413-4","volume":"15","author":"Z Li","year":"2020","unstructured":"Li Z, Shue F, Zhao N, Shinohara M, Bu G. APOE2: protective mechanism and therapeutic implications for Alzheimer\u2019s disease. Mol Neurodegener. 2020;15:63. https:\/\/doi.org\/10.1186\/s13024-020-00413-4.","journal-title":"Mol Neurodegener"},{"key":"935_CR27","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.3233\/jad-200019","volume":"77","author":"C Olive","year":"2020","unstructured":"Olive C, Ibanez L, Farias FHG, Wang F, Budde JP, Norton JB, Gentsch J, Morris JC, Li Z, Dube U, et al. Examination of the Effect of Rare Variants in TREM2, ABI3, and PLCG2 in LOAD Through Multiple Phenotypes. J Alzheimers Dis. 2020;77:1469\u201382. https:\/\/doi.org\/10.3233\/jad-200019.","journal-title":"J Alzheimers Dis"},{"key":"935_CR28","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/s41588-020-00776-w","volume":"53","author":"J Schwartzentruber","year":"2021","unstructured":"Schwartzentruber J, Cooper S, Liu JZ, Barrio-Hernandez I, Bello E, Kumasaka N, Young AMH, Franklin RJM, Johnson T, Estrada K, et al. Genome-wide meta-analysis, fine-mapping and integrative prioritization implicate new Alzheimer\u2019s disease risk genes. Nat Genet. 2021;53:392\u2013402. https:\/\/doi.org\/10.1038\/s41588-020-00776-w.","journal-title":"Nat Genet"},{"key":"935_CR29","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s00401-019-02026-8","volume":"138","author":"SJ van der Lee","year":"2019","unstructured":"van der Lee SJ, Conway OJ, Jansen I, Carrasquillo MM, Kleineidam L, van den Akker E, Hern\u00e1ndez I, van Eijk KR, Stringa N, Chen JA, et al. A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer\u2019s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity. Acta Neuropathol. 2019;138:237\u201350. https:\/\/doi.org\/10.1007\/s00401-019-02026-8.","journal-title":"Acta Neuropathol"},{"key":"935_CR30","doi-asserted-by":"publisher","first-page":"748781","DOI":"10.3389\/fgene.2021.748781","volume":"12","author":"N Tesi","year":"2021","unstructured":"Tesi N, Hulsman M, van der Lee SJ, Jansen IE, Stringa N, van Schoor NM, Scheltens P, van der Flier WM, Huisman M, Reinders MJT, Holstege H. The Effect of Alzheimer\u2019s Disease-Associated Genetic Variants on Longevity. Front Genet. 2021;12:748781. https:\/\/doi.org\/10.3389\/fgene.2021.748781.","journal-title":"Front Genet"},{"key":"935_CR31","doi-asserted-by":"publisher","unstructured":"Tsai AP, Dong C, Preuss C, Moutinho M, Lin PB-C, Hajicek N, Sondek J, Bissel SJ, Oblak AL, Carter GW, et al. PLCG2\u2009as a Risk Factor for Alzheimer\u2019s Disease. bioRxiv. 2020;202020052019104216. https:\/\/doi.org\/10.1101\/2020.05.19.104216.","DOI":"10.1101\/2020.05.19.104216"},{"key":"935_CR32","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.jaci.2023.08.036","volume":"153","author":"K Baysac","year":"2024","unstructured":"Baysac K, Sun G, Nakano H, Schmitz EG, Cruz AC, Fisher C, Bailey AC, Mace E, Milner JD, Ombrello MJ. PLCG2-associated immune dysregulation (PLAID) comprises broad and distinct clinical presentations related to functional classes of genetic variants. J Allergy Clin Immunol. 2024;153:230\u201342. https:\/\/doi.org\/10.1016\/j.jaci.2023.08.036.","journal-title":"J Allergy Clin Immunol"},{"key":"935_CR33","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1056\/NEJMoa1102140","volume":"366","author":"MJ Ombrello","year":"2012","unstructured":"Ombrello MJ, Remmers EF, Sun G, Freeman AF, Datta S, Torabi-Parizi P, Subramanian N, Bunney TD, Baxendale RW, Martins MS, et al. Cold urticaria, immunodeficiency, and autoimmunity related to PLCG2 deletions. N Engl J Med. 2012;366:330\u20138. https:\/\/doi.org\/10.1056\/NEJMoa1102140.","journal-title":"N Engl J Med"},{"key":"935_CR34","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1007\/s00401-020-02138-6","volume":"139","author":"L Kleineidam","year":"2020","unstructured":"Kleineidam L, Chouraki V, Pr\u00f3chnicki T, van der Lee SJ, Madrid-M\u00e1rquez L, Wagner-Thelen H, Karaca I, Weinhold L, Wolfsgruber S, Boland A, et al. PLCG2 protective variant p.P522R modulates tau pathology and disease progression in patients with mild cognitive impairment. Acta Neuropathol. 2020;139:1025\u201344. https:\/\/doi.org\/10.1007\/s00401-020-02138-6.","journal-title":"Acta Neuropathol"},{"key":"935_CR35","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41398-019-0394-9","volume":"9","author":"MC Dalmasso","year":"2019","unstructured":"Dalmasso MC, Brusco LI, Olivar N, Muchnik C, Hanses C, Milz E, Becker J, Heilmann-Heimbach S, Hoffmann P, Prestia FA, et al. Transethnic meta-analysis of rare coding variants in PLCG2, ABI3, and TREM2 supports their general contribution to Alzheimer\u2019s disease. Translational Psychiatry. 2019;9:55. https:\/\/doi.org\/10.1038\/s41398-019-0394-9.","journal-title":"Translational Psychiatry"},{"key":"935_CR36","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13073-022-01022-0","volume":"14","author":"AP Tsai","year":"2022","unstructured":"Tsai AP, Dong C, Lin PB-C, Messenger EJ, Casali BT, Moutinho M, Liu Y, Oblak AL, Lamb BT, Landreth GE, et al. PLCG2 is associated with the inflammatory response and is induced by amyloid plaques in Alzheimer\u2019s disease. Genome Med. 2022;14:17. https:\/\/doi.org\/10.1186\/s13073-022-01022-0.","journal-title":"Genome Med"},{"key":"935_CR37","doi-asserted-by":"publisher","first-page":"4153","DOI":"10.1016\/j.cell.2022.09.033","volume":"185","author":"S Wang","year":"2022","unstructured":"Wang S, Sudan R, Peng V, Zhou Y, Du S, Yuede CM, Lei T, Hou J, Cai Z, Cella M, et al. TREM2 drives microglia response to amyloid-\u03b2 via SYK-dependent and -independent pathways. Cell. 2022;185:4153\u2013e41694119. https:\/\/doi.org\/10.1016\/j.cell.2022.09.033.","journal-title":"Cell"},{"key":"935_CR38","doi-asserted-by":"publisher","first-page":"4135","DOI":"10.1016\/j.cell.2022.09.030","volume":"185","author":"H Ennerfelt","year":"2022","unstructured":"Ennerfelt H, Frost EL, Shapiro DA, Holliday C, Zengeler KE, Voithofer G, Bolte AC, Lammert CR, Kulas JA, Ulland TK, Lukens JR. SYK coordinates neuroprotective microglial responses in neurodegenerative disease. Cell. 2022;185:4135\u2013e41524122. https:\/\/doi.org\/10.1016\/j.cell.2022.09.030.","journal-title":"Cell"},{"key":"935_CR39","doi-asserted-by":"publisher","first-page":"100905","DOI":"10.1016\/j.jbc.2021.100905","volume":"297","author":"JT Jackson","year":"2021","unstructured":"Jackson JT, Mulazzani E, Nutt SL, Masters SL. The role of PLC\u03b32 in immunological disorders, cancer, and neurodegeneration. J Biol Chem. 2021;297:100905. https:\/\/doi.org\/10.1016\/j.jbc.2021.100905.","journal-title":"J Biol Chem"},{"key":"935_CR40","doi-asserted-by":"publisher","first-page":"9986","DOI":"10.1128\/mcb.24.22.9986-9999.2004","volume":"24","author":"YJ Kim","year":"2004","unstructured":"Kim YJ, Sekiya F, Poulin B, Bae YS, Rhee SG. Mechanism of B-cell receptor-induced phosphorylation and activation of phospholipase C-gamma2. Mol Cell Biol. 2004;24:9986\u201399. https:\/\/doi.org\/10.1128\/mcb.24.22.9986-9999.2004.","journal-title":"Mol Cell Biol"},{"key":"935_CR41","doi-asserted-by":"publisher","first-page":"22136","DOI":"10.1074\/jbc.M116.746842","volume":"291","author":"C Walliser","year":"2016","unstructured":"Walliser C, Hermkes E, Schade A, Wiese S, Deinzer J, Zapatka M, Desire L, Mertens D, Stilgenbauer S, Gierschik P. The Phospholipase Cgamma2 Mutants R665W and L845F Identified in Ibrutinib-resistant Chronic Lymphocytic Leukemia Patients Are Hypersensitive to the Rho GTPase Rac2 Protein. J Biol Chem. 2016;291:22136\u201348. https:\/\/doi.org\/10.1074\/jbc.M116.746842.","journal-title":"J Biol Chem"},{"key":"935_CR42","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1056\/NEJMoa1400029","volume":"370","author":"JA Woyach","year":"2014","unstructured":"Woyach JA, Furman RR, Liu TM, Ozer HG, Zapatka M, Ruppert AS, Xue L, Li DH, Steggerda SM, Versele M, et al. Resistance mechanisms for the Bruton\u2019s tyrosine kinase inhibitor ibrutinib. N Engl J Med. 2014;370:2286\u201394. https:\/\/doi.org\/10.1056\/NEJMoa1400029.","journal-title":"N Engl J Med"},{"key":"935_CR43","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1007\/s11481-019-09839-0","volume":"14","author":"J Keaney","year":"2019","unstructured":"Keaney J, Gasser J, Gillet G, Scholz D, Kadiu I. Inhibition of Bruton\u2019s Tyrosine Kinase Modulates Microglial Phagocytosis: Therapeutic Implications for Alzheimer\u2019s Disease. J Neuroimmune Pharmacol. 2019;14:448\u201361. https:\/\/doi.org\/10.1007\/s11481-019-09839-0.","journal-title":"J Neuroimmune Pharmacol"},{"key":"935_CR44","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1038\/s41590-023-01473-6","volume":"24","author":"E Mulazzani","year":"2023","unstructured":"Mulazzani E, Kong K, Ar\u00f3stegui JI, Ng AP, Ranathunga N, Abeysekera W, Garnham AL, Ng S-L, Baker PJ, Jackson JT, et al. G-CSF drives autoinflammation in APLAID. Nat Immunol. 2023;24:814\u201326. https:\/\/doi.org\/10.1038\/s41590-023-01473-6.","journal-title":"Nat Immunol"},{"key":"935_CR45","doi-asserted-by":"publisher","first-page":"34357","DOI":"10.18632\/oncotarget.26173","volume":"9","author":"C Walliser","year":"2018","unstructured":"Walliser C, Wist M, Hermkes E, Zhou Y, Schade A, Haas J, Deinzer J, D\u00e9sir\u00e9 L, Li SSC, Stilgenbauer S, et al. Functional characterization of phospholipase C-\u03b3(2) mutant protein causing both somatic ibrutinib resistance and a germline monogenic autoinflammatory disorder. Oncotarget. 2018;9:34357\u201378. https:\/\/doi.org\/10.18632\/oncotarget.26173.","journal-title":"Oncotarget"},{"key":"935_CR46","doi-asserted-by":"publisher","first-page":"eadn6037","DOI":"10.1126\/sciadv.adn6037","volume":"10","author":"YC Shin","year":"2024","unstructured":"Shin YC, Plummer-Medeiros AM, Mungenast A, Choi HW, TenDyke K, Zhu X, Shepard J, Sanders K, Zhuang N, Hu L, et al. The crystal and cryo-EM structures of PLC\u03b32 reveal dynamic interdomain recognitions in autoinhibition. Sci Adv. 2024;10:eadn6037. https:\/\/doi.org\/10.1126\/sciadv.adn6037.","journal-title":"Sci Adv"},{"key":"935_CR47","doi-asserted-by":"publisher","first-page":"166978","DOI":"10.1016\/j.bbadis.2023.166978","volume":"1870","author":"D Bull","year":"2024","unstructured":"Bull D, Matte JC, Navarron CM, McIntyre R, Whiting P, Katan M, Ducotterd F, Magno L. The hypermorphic PLC\u03b32 S707Y variant dysregulates microglial cell function - Insight into PLC\u03b32 activation in brain health and disease, and opportunities for therapeutic modulation. Biochim Biophys Acta Mol Basis Dis. 2024;1870:166978. https:\/\/doi.org\/10.1016\/j.bbadis.2023.166978.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"935_CR48","doi-asserted-by":"publisher","first-page":"e51700","DOI":"10.7554\/eLife.51700","volume":"8","author":"N Hajicek","year":"2019","unstructured":"Hajicek N, Keith NC, Siraliev-Perez E, Temple BRS, Huang W, Zhang Q, Harden TK, Sondek J. Structural basis for the activation of PLC-\u03b3 isozymes by phosphorylation and cancer-associated mutations. eLife. 2019;8:e51700. https:\/\/doi.org\/10.7554\/eLife.51700.","journal-title":"eLife"},{"key":"935_CR49","doi-asserted-by":"publisher","first-page":"108356","DOI":"10.1016\/j.jbc.2025.108356","volume":"301","author":"AJ Carr","year":"2025","unstructured":"Carr AJ, Hajicek N, Tsai AP, Acharya PP, Hardy PB, Meyer E, Wyss-Coray T, Pearce KH, Sondek J, Zhang Q. A high-throughput assay platform to discover small molecule activators of the phospholipase PLC-\u03b32 to treat Alzheimer\u2019s disease. J Biol Chem. 2025;301:108356. https:\/\/doi.org\/10.1016\/j.jbc.2025.108356.","journal-title":"J Biol Chem"},{"key":"935_CR50","doi-asserted-by":"publisher","first-page":"4117","DOI":"10.1016\/j.cell.2023.07.027","volume":"186","author":"O Hahn","year":"2023","unstructured":"Hahn O, Foltz AG, Atkins M, Kedir B, Moran-Losada P, Guldner IH, Munson C, Kern F, P\u00e1lovics R, Lu N, et al. Atlas of the aging mouse brain reveals white matter as vulnerable foci. Cell. 2023;186:4117\u2013e41334122. https:\/\/doi.org\/10.1016\/j.cell.2023.07.027.","journal-title":"Cell"},{"key":"935_CR51","doi-asserted-by":"publisher","first-page":"e70231","DOI":"10.1002\/alz.70231","volume":"21","author":"EJ Messenger","year":"2025","unstructured":"Messenger EJ, Baar SA, Bedford LM, Tsai AP, Lin PB, Ferguson CA, Xu G, Wallace A, Landreth GE, Lamb BT, Bissel SJ. PLCG2 modulates TREM2 expression and signaling in response to Alzheimer\u2019s disease pathology. Alzheimers Dement. 2025;21:e70231. https:\/\/doi.org\/10.1002\/alz.70231.","journal-title":"Alzheimers Dement"},{"key":"935_CR52","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41586-025-09662-z","volume":"648","author":"P Ayata","year":"2025","unstructured":"Ayata P, Crowley JM, Challman MF, Sahasrabuddhe V, Gratuze M, Werneburg S, Ribeiro D, Hays EC, Dur\u00e1n-Laforet V, Faust TE, et al. Lymphoid gene expression supports neuroprotective microglia function. Nature. 2025;648:157\u201365. https:\/\/doi.org\/10.1038\/s41586-025-09662-z.","journal-title":"Nature"},{"key":"935_CR53","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13024-020-00402-7","volume":"15","author":"M Takalo","year":"2020","unstructured":"Takalo M, Wittrahm R, Wefers B, Parhizkar S, Jokivarsi K, Kuulasmaa T, Makinen P, Martiskainen H, Wurst W, Xiang X, et al. The Alzheimer\u2019s disease-associated protective Plcgamma2-P522R variant promotes immune functions. Mol Neurodegener. 2020;15:52. https:\/\/doi.org\/10.1186\/s13024-020-00402-7.","journal-title":"Mol Neurodegener"},{"key":"935_CR54","doi-asserted-by":"publisher","DOI":"10.1002\/alz.12577","author":"C Claes","year":"2022","unstructured":"Claes C, England WE, Danhash EP, Kiani Shabestari S, Jairaman A, Chadarevian JP, Hasselmann J, Tsai AP, Coburn MA, Sanchez J, et al. The P522R protective variant of PLCG2 promotes the expression of antigen presentation genes by human microglia in an Alzheimer\u2019s disease mouse model. Alzheimers Dement. 2022. https:\/\/doi.org\/10.1002\/alz.12577.","journal-title":"Alzheimers Dement"},{"key":"935_CR55","doi-asserted-by":"publisher","unstructured":"Coulon A, Rabiller F, Takalo M, Roy A, Martiskainen H, Siedlecki-Wullich D, Mendes T, Lemeu C, Carvalho L-I, Ehrardt A et al. (2024). Neuronal downregulation of <\u2009em>PLCG2 impairs synaptic function and elicits Alzheimer disease hallmarks. bioRxiv, 2024.2004.2029.591575. https:\/\/doi.org\/10.1101\/2024.04.29.591575","DOI":"10.1101\/2024.04.29.591575"},{"key":"935_CR56","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s00018-022-04473-1","volume":"79","author":"S Solomon","year":"2022","unstructured":"Solomon S, Sampathkumar NK, Carre I, Mondal M, Chennell G, Vernon AC, Ruepp M-D, Mitchell JC. Heterozygous expression of the Alzheimer\u2019s disease-protective PLC\u03b32 P522R variant enhances A\u03b2 clearance while preserving synapses. Cell Mol Life Sci. 2022;79:453. https:\/\/doi.org\/10.1007\/s00018-022-04473-1.","journal-title":"Cell Mol Life Sci"},{"key":"935_CR57","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s40478-020-01050-0","volume":"8","author":"SL Strickland","year":"2020","unstructured":"Strickland SL, Morel H, Prusinski C, Allen M, Patel TA, Carrasquillo MM, Conway OJ, Lincoln SJ, Reddy JS, Nguyen T, et al. Association of ABI3 and PLCG2 missense variants with disease risk and neuropathology in Lewy body disease and progressive supranuclear palsy. Acta Neuropathol Commun. 2020;8:172. https:\/\/doi.org\/10.1186\/s40478-020-01050-0.","journal-title":"Acta Neuropathol Commun"},{"key":"935_CR58","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41586-019-1895-7","volume":"577","author":"D Gate","year":"2020","unstructured":"Gate D, Saligrama N, Leventhal O, Yang AC, Unger MS, Middeldorp J, Chen K, Lehallier B, Channappa D, De Los Santos MB, et al. Clonally expanded CD8 T cells patrol the cerebrospinal fluid in Alzheimer\u2019s disease. Nature. 2020;577:399\u2013404. https:\/\/doi.org\/10.1038\/s41586-019-1895-7.","journal-title":"Nature"},{"key":"935_CR59","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/s41586-023-05788-0","volume":"615","author":"X Chen","year":"2023","unstructured":"Chen X, Firulyova M, Manis M, Herz J, Smirnov I, Aladyeva E, Wang C, Bao X, Finn MB, Hu H, et al. Microglia-mediated T cell infiltration drives neurodegeneration in tauopathy. Nature. 2023;615:668\u201377. https:\/\/doi.org\/10.1038\/s41586-023-05788-0.","journal-title":"Nature"},{"key":"935_CR60","doi-asserted-by":"publisher","first-page":"886575","DOI":"10.3389\/fnagi.2022.886575","volume":"14","author":"AL Oblak","year":"2022","unstructured":"Oblak AL, Kotredes KP, Pandey RS, Reagan AM, Ingraham C, Perkins B, Lloyd C, Baker D, Lin PB, Soni DM, et al. Plcg2(M28L) Interacts With High Fat\/High Sugar Diet to Accelerate Alzheimer\u2019s Disease-Relevant Phenotypes in Mice. Front Aging Neurosci. 2022;14:886575. https:\/\/doi.org\/10.3389\/fnagi.2022.886575.","journal-title":"Front Aging Neurosci"},{"key":"935_CR61","doi-asserted-by":"publisher","unstructured":"Reilly AM, Tsai AP, Lin PB, Ericsson AC, Oblak AL, Ren H. Metabolic Defects Caused by High-Fat Diet Modify Disease Risk through Inflammatory and Amyloidogenic Pathways in a Mouse Model of Alzheimer\u2019s Disease. Nutrients. 2020;12. https:\/\/doi.org\/10.3390\/nu12102977.","DOI":"10.3390\/nu12102977"},{"key":"935_CR62","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12974-025-03387-6","volume":"22","author":"M Takalo","year":"2025","unstructured":"Takalo M, Jeskanen H, Rolova T, Kervinen I, Hell\u00e9n M, Heikkinen S, Koivisto H, Jokivarsi K, M\u00fcller SA, Koivum\u00e4ki EM, et al. The protective PLC\u03b32-P522R variant mitigates Alzheimer\u2019s disease-associated pathologies by enhancing beneficial microglial functions. J Neuroinflammation. 2025;22:64. https:\/\/doi.org\/10.1186\/s12974-025-03387-6.","journal-title":"J Neuroinflammation"},{"key":"935_CR63","doi-asserted-by":"publisher","first-page":"19842","DOI":"10.1038\/s41598-021-96144-7","volume":"11","author":"J Obst","year":"2021","unstructured":"Obst J, Hall-Roberts HL, Smith TB, Kreuzer M, Magno L, Di Daniel E, Davis JB, Mead E. PLC\u03b32 regulates TREM2 signalling and integrin-mediated adhesion and migration of human iPSC-derived macrophages. Sci Rep. 2021;11:19842. https:\/\/doi.org\/10.1038\/s41598-021-96144-7.","journal-title":"Sci Rep"},{"key":"935_CR64","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1038\/s41593-020-0650-6","volume":"23","author":"BJ Andreone","year":"2020","unstructured":"Andreone BJ, Przybyla L, Llapashtica C, Rana A, Davis SS, van Lengerich B, Lin K, Shi J, Mei Y, Astarita G, et al. Alzheimer\u2019s-associated PLC\u03b32 is a signaling node required for both TREM2 function and the inflammatory response in human microglia. Nat Neurosci. 2020;23:927\u201338. https:\/\/doi.org\/10.1038\/s41593-020-0650-6.","journal-title":"Nat Neurosci"},{"key":"935_CR65","doi-asserted-by":"publisher","unstructured":"Li R-Y, Qin Q, Yang H-C, Wang Y-Y, Mi Y-X, Yin Y-S, Wang M, Yu C-J, Tang Y. TREM2 in the pathogenesis of AD: a lipid metabolism regulator and potential metabolic therapeutic target. Mol Neurodegeneration. 2022;17. https:\/\/doi.org\/10.1186\/s13024-022-00542-y.","DOI":"10.1186\/s13024-022-00542-y"},{"key":"935_CR66","doi-asserted-by":"publisher","unstructured":"Jing H, Reed A, Ulanovskaya OA, Grigoleit JS, Herbst DM, Henry CL, Li H, Barbas S, Germain J, Masuda K, Cravatt BF. Phospholipase C\u03b32 regulates endocannabinoid and eicosanoid networks in innate immune cells. Proc Natl Acad Sci USA. 2021;118. https:\/\/doi.org\/10.1073\/pnas.2112971118","DOI":"10.1073\/pnas.2112971118"},{"key":"935_CR67","doi-asserted-by":"publisher","DOI":"10.1101\/2023.12.06.570499","author":"SC Hopp","year":"2023","unstructured":"Hopp SC, Rogers JG, Smith S, Campos G, Miller H, Barannikov S, Kuri EG, Wang H, Han X, Bieniek KF, et al. Multi-omics analyses reveal novel effects of PLC\u03b32 deficiency in the mouse brain. bioRxiv. 2023. https:\/\/doi.org\/10.1101\/2023.12.06.570499.","journal-title":"bioRxiv"},{"key":"935_CR68","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","volume":"169","author":"H Keren-Shaul","year":"2017","unstructured":"Keren-Shaul H, Spinrad A, Weiner A, Matcovitch-Natan O, Dvir-Szternfeld R, Ulland TK, David E, Baruch K, Lara-Astaiso D, Toth B, et al. A Unique Microglia Type Associated with Restricting Development of Alzheimer\u2019s Disease. Cell. 2017;169:1276\u2013e12901217. https:\/\/doi.org\/10.1016\/j.cell.2017.05.018.","journal-title":"Cell"},{"key":"935_CR69","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/978-1-0716-1142-5_17","volume":"2251","author":"AJ Carr","year":"2021","unstructured":"Carr AJ, Siraliev-Perez E, Huang W, Sondek J, Zhang Q. Fluorogenic XY-69 in Lipid Vesicles for Measuring Activity of Phospholipase C Isozymes. Methods Mol Biol. 2021;2251:225\u201336. https:\/\/doi.org\/10.1007\/978-1-0716-1142-5_17.","journal-title":"Methods Mol Biol"},{"key":"935_CR70","doi-asserted-by":"publisher","first-page":"4029","DOI":"10.1021\/acs.biochem.0c00511","volume":"59","author":"W Huang","year":"2020","unstructured":"Huang W, Carr AJ, Hajicek N, Sokolovski M, Siraliev-Perez E, Hardy PB, Pearce KH, Sondek J, Zhang Q. A High-Throughput Assay to Identify Allosteric Inhibitors of the PLC-\u03b3 Isozymes Operating at Membranes. Biochemistry. 2020;59:4029\u201338. https:\/\/doi.org\/10.1021\/acs.biochem.0c00511.","journal-title":"Biochemistry"},{"key":"935_CR71","doi-asserted-by":"publisher","first-page":"842","DOI":"10.3389\/fneur.2018.00842","volume":"9","author":"J D\u00f6rr","year":"2018","unstructured":"D\u00f6rr J, Wernecke KD, W\u00fcrfel J, Bellmann-Strobl J, Siffrin V, S\u00e4ttler MB, Simons M, Linsa A, Tumani H, Paul F. Disease Modification in Multiple Sclerosis by Flupirtine-Results of a Randomized Placebo Controlled Phase II Trial. Front Neurol. 2018;9:842. https:\/\/doi.org\/10.3389\/fneur.2018.00842.","journal-title":"Front Neurol"},{"key":"935_CR72","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/ncpneuro0978","volume":"5","author":"Flupirtine is a promising agent for the treatment of autoimmune optic neuritis","year":"2009","unstructured":"Flupirtine is a promising agent for the treatment of autoimmune optic neuritis. Nat Clin Pract Neurol. 2009;5:63\u20134. https:\/\/doi.org\/10.1038\/ncpneuro0978.","journal-title":"Nat Clin Pract Neurol"},{"key":"935_CR73","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.2353\/ajpath.2008.080491","volume":"173","author":"MB S\u00e4ttler","year":"2008","unstructured":"S\u00e4ttler MB, Williams SK, Neusch C, Otto M, Pehlke JR, B\u00e4hr M, Diem R. Flupirtine as neuroprotective add-on therapy in autoimmune optic neuritis. Am J Pathol. 2008;173:1496\u2013507. https:\/\/doi.org\/10.2353\/ajpath.2008.080491.","journal-title":"Am J Pathol"},{"key":"935_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbr.2015.04.004","volume":"288","author":"P Huang","year":"2015","unstructured":"Huang P, Li C, Fu T, Zhao D, Yi Z, Lu Q, Guo L, Xu X. Flupirtine attenuates chronic restraint stress-induced cognitive deficits and hippocampal apoptosis in male mice. Behav Brain Res. 2015;288:1\u201310. https:\/\/doi.org\/10.1016\/j.bbr.2015.04.004.","journal-title":"Behav Brain Res"},{"key":"935_CR75","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/s1074-7613(00)00005-4","volume":"13","author":"D Wang","year":"2000","unstructured":"Wang D, Feng J, Wen R, Marine JC, Sangster MY, Parganas E, Hoffmeyer A, Jackson CW, Cleveland JL, Murray PJ, Ihle JN. Phospholipase Cgamma2 is essential in the functions of B cell and several Fc receptors. Immunity. 2000;13:25\u201335. https:\/\/doi.org\/10.1016\/s1074-7613(00)00005-4.","journal-title":"Immunity"},{"key":"935_CR76","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13024-023-00604-9","volume":"18","author":"AM Diks","year":"2023","unstructured":"Diks AM, Teodosio C, de Mooij B, Groenland RJ, Naber BAE, de Laat IF, Vloemans SA, Rohde S, de Jonge MI, Lorenz L, et al. Carriers of the p.P522R variant in PLC\u03b32 have a slightly more responsive immune system. Mol Neurodegener. 2023;18:25. https:\/\/doi.org\/10.1186\/s13024-023-00604-9.","journal-title":"Mol Neurodegener"},{"key":"935_CR77","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3233\/jad-201140","volume":"80","author":"F Chen","year":"2021","unstructured":"Chen F, Zhang Y, Wang L, Wang T, Han Z, Zhang H, Gao S, Hu Y, Liu G. PLCG2 rs72824905 Variant Reduces the Risk of Alzheimer\u2019s Disease and Multiple Sclerosis. J Alzheimers Dis. 2021;80:71\u20137. https:\/\/doi.org\/10.3233\/jad-201140.","journal-title":"J Alzheimers Dis"}],"container-title":["Molecular Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-026-00935-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13024-026-00935-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-026-00935-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:56:31Z","timestamp":1781643391000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13024-026-00935-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,26]]},"references-count":77,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["935"],"URL":"https:\/\/doi.org\/10.1186\/s13024-026-00935-3","relation":{},"ISSN":["1750-1326"],"issn-type":[{"value":"1750-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,26]]},"assertion":[{"value":"19 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20"}}